Posted on Leave a comment

Up-scaling the differentiation of functional cardiomyocytes.

A key area of research for the EBiSC team is focusing on robust iPSC cardiac differentiation, generating cardiomyocytes from both healthy donors and patients with cardiac disease. Alongside optimising protocols for differentiation, upscaling and cryopreservation, we offer characterisation and functional phenotyping services to support disease modelling and drug discovery.

By combining high-quality iPSC resources with expert differentiation and analysis, EBiSC helps researchers build reliable, human-relevant cardiac models.

Get in touch via Contact@EBiSC.org to discuss your needs.

Posted on Leave a comment

Big news for biomedical researchers in Australia and New Zealand!

We’re excited to announce that CellBank Australia is now the official distributor of the EBiSC stem cell collection for Australia and New Zealand — making it easier than ever for researchers across Oceania to access 950+ high-quality iPSC lines covering more than 45 disease areas, including cardiovascular, neurological, and metabolic disorders.

This partnership expands EBiSC’s global reach, ensuring that our validated iPSC lines and pre-differentiated cells are available to support research in disease modelling, drug discovery, and regenerative medicine across the region.

Operated by the Children’s Medical Research Institute (CMRI), CellBank brings 18+ years of expertise in authenticated cell lines and quality control services. The collaboration is further strengthened by CMRI’s Stem Cell and Organoid Facility, advancing 3D organoid models and translational research.

📧 cellbank@cmri.org.au

🌐 https://www.cellbankaustralia.com/cell-lines-for-distribution/